Theravance Biopharma, Inc. Ordinary Shares (NASDAQ: TBPH) last traded at $17.03, up 0.00% on the session. The quote above updates while this page is open; the figures below are drawn from Theravance Biopharma, Inc. Ordinary Shares’s own filings and are restated only when a new one is published.
Theravance Biopharma, Inc. Ordinary Shares trades on NASDAQ under the ticker TBPH. Its market capitalisation is $884.18 million.
Valuation measures for Theravance Biopharma, Inc. Ordinary Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $884.18M |
|---|---|
| Enterprise value | $844.48M |
| P/E ratio | 16.86 |
| Price / sales | 8.48 |
| Price / book | 3.05 |
Trailing-twelve-month figures tagged in Theravance Biopharma, Inc. Ordinary Shares's XBRL filings with the SEC.
| Revenue (TTM) | $104.31M |
|---|---|
| Net income (TTM) | $53.81M |
| EPS (TTM) | $1.01 |
| Operating margin | -4.03% |
| Return on equity | 18.57% |
| Cash | $219.77M |
Range and volume for TBPH over the past 52 weeks.
| 52-week high | $21.03 |
|---|---|
| 52-week low | $13.08 |
| Volume | 10.02M |
| Average volume | 10.04M |
| Previous close | $17.03 |
Invest a chosen dollar amount in Theravance Biopharma, Inc. Ordinary Shares with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell TBPH.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.